These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38741406)

  • 1. Release mechanism and pharmacodynamics of entecavir micro spheres.
    Zhang C; Chu L; Li K; Yan M
    Pak J Pharm Sci; 2024 Jan; 37(1):107-113. PubMed ID: 38741406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Entecavir-loaded poly (lactic-co-glycolic acid) microspheres for long-term therapy of chronic hepatitis-B: Preparation and in vitro and in vivo evaluation.
    Zhang C; Wang A; Wang H; Yan M; Liang R; He X; Fu F; Mu H; Sun K
    Int J Pharm; 2019 Apr; 560():27-34. PubMed ID: 30711615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological properties and clinical efficacy of entecavir monohydrate (Baraclude Tablet 0.5 mg), an anti-HBV drug].
    Amano M; Goto A
    Nihon Yakurigaku Zasshi; 2007 Apr; 129(4):287-97. PubMed ID: 17435342
    [No Abstract]   [Full Text] [Related]  

  • 4. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
    Liu Y; Yao W; Si L; Hou J; Wang J; Xu Z; Li W; Chen J; Li R; Li P; Bo L; Xiao X; Lan J; Xu D
    Antiviral Res; 2018 Jul; 155():39-47. PubMed ID: 29702120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres.
    Liu B; Dong Q; Wang M; Shi L; Wu Y; Yu X; Shi Y; Shan Y; Jiang C; Zhang X; Gu T; Chen Y; Kong W
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1474-9. PubMed ID: 21048339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interfacial Fast Release Layer in Monodisperse Poly (lactic-co-glycolic acid) Microspheres Accelerates the Drug Release.
    Wu J; Zhao X; Yeung KW; To MK
    Curr Drug Deliv; 2016; 13(5):720-9. PubMed ID: 26638974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of long-acting implant formulations of hepatitis B drug entecavir.
    Henry SJ; Barrett SE; Forster SP; Teller RS; Yang Z; Li L; Mackey MA; Doto GJ; Ruth MP; Tsuchiya T; Klein LJ; Gindy ME
    Eur J Pharm Sci; 2019 Aug; 136():104958. PubMed ID: 31212018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine.
    Geipel A; Seiz PL; Niekamp H; Neumann-Fraune M; Zhang K; Kaiser R; Protzer U; Gerlich WH; Glebe D;
    Antivir Ther; 2015; 20(8):779-87. PubMed ID: 25560463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
    Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
    Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable PLGA Adefovir microspheres; the way for long term therapy of chronic hepatitis-B.
    Ayoub MM; Elantouny NG; El-Nahas HM; Ghazy FES
    Eur J Pharm Sci; 2018 Jun; 118():24-31. PubMed ID: 29555501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid jet breakup: A new method for the preparation of poly lactic-co-glycolic acid microspheres.
    Xia Y; Yuan M; Chen M; Li J; Ci T; Ke X
    Eur J Pharm Biopharm; 2019 Apr; 137():140-147. PubMed ID: 30818010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro degradation study of polyester microspheres by a new HPLC method for monomer release determination.
    Giunchedi P; Conti B; Scalia S; Conte U
    J Control Release; 1998 Dec; 56(1-3):53-62. PubMed ID: 9801429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics.
    Gabor F; Ertl B; Wirth M; Mallinger R
    J Microencapsul; 1999; 16(1):1-12. PubMed ID: 9972498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HBV drug entecavir - effects on HIV-1 replication and resistance.
    McMahon MA; Jilek BL; Brennan TP; Shen L; Zhou Y; Wind-Rotolo M; Xing S; Bhat S; Hale B; Hegarty R; Chong CR; Liu JO; Siliciano RF; Thio CL
    N Engl J Med; 2007 Jun; 356(25):2614-21. PubMed ID: 17582071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics and pharmacodynamics of lidocaine- loaded biodegradable poly(lactic-co-glycolic acid) microspheres.
    Liu J; Lv X
    Int J Mol Sci; 2014 Sep; 15(10):17469-77. PubMed ID: 25268618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrospray synthesis and properties of hierarchically structured PLGA TIPS microspheres for use as controlled release technologies.
    Malik SA; Ng WH; Bowen J; Tang J; Gomez A; Kenyon AJ; Day RM
    J Colloid Interface Sci; 2016 Apr; 467():220-229. PubMed ID: 26803601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil accelerates the release of PLGA microparticles via catalyzing the polymer degradation regardless of the end groups and molecular weights.
    Quan P; Guo W; LinYang ; Cun D; Yang M
    Int J Pharm; 2023 Feb; 632():122566. PubMed ID: 36586633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liraglutide-loaded poly(lactic-co-glycolic acid) microspheres: Preparation and in vivo evaluation.
    Wu J; Williams GR; Branford-White C; Li H; Li Y; Zhu LM
    Eur J Pharm Sci; 2016 Sep; 92():28-38. PubMed ID: 27343696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
    Reijnders JG; Deterding K; Petersen J; Zoulim F; Santantonio T; Buti M; van Bömmel F; Hansen BE; Wedemeyer H; Janssen HL;
    J Hepatol; 2010 Apr; 52(4):493-500. PubMed ID: 20185191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycyrrhetic acid, but not glycyrrhizic acid, strengthened entecavir activity by promoting its subcellular distribution in the liver via efflux inhibition.
    Chen Q; Chen H; Wang W; Liu J; Liu W; Ni P; Sang G; Wang G; Zhou F; Zhang J
    Eur J Pharm Sci; 2017 Aug; 106():313-327. PubMed ID: 28627473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.